Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against...

Keywords

AtenololMedicineLosartanBlood pressureMyocardial infarctionStroke (engine)CardiologyInternal medicineLeft ventricular hypertrophyClinical endpointAngiotensin IIRandomized controlled trial

Affiliated Institutions

Related Publications

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

M R Law , Joan K. Morris , Nicholas Wald

With the exception of the extra protective effect of beta blockers given shortly after a myocardial infarction and the minor additional effect of calcium channel blockers in pre...

2009 BMJ 2727 citations

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials

Costas Thomopoulos , Gianfranco Parati , Alberto Zanchetti

Meta-analyses of all BP-lowering RCTs involving hypertensive patients provide precise estimates of benefits (larger for stroke and heart failure, but also significant for CHD an...

2014 Journal of Hypertension 364 citations

Pathophysiology of Valvular Aortic Stenois in the Elderly

Melvin D. Cheitlin

Aortic stenosis in the elderly is related to calcification of either a bicuspid valve or a morphologically normal tricuspid valve. There is increasing evidence that factors rela...

2003 The American Journal of Geriatric Car... 13 citations

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke

François Gueyffier , Jean‐Pierre Boissel , Florent Boutitie +10 more

Background and Purpose Drug treatment of high blood pressure has been shown to reduce the associated cardiovascular risk. Stroke represents the type of event more strongly linke...

1997 Stroke 247 citations

Decline in Cardiovascular Mortality

George A. Mensah , Gina S. Wei , Paul D. Sorlie +8 more

If the control of infectious diseases was the public health success story of the first half of the 20th century, then the decline in mortality from coronary heart disease and st...

2017 Circulation Research 785 citations

Publication Info

Year: 2002
Type: article
Volume: 359
Issue: 9311
Pages: 995-1003
Citations: 5386
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

5386

OpenAlex

Cite This

APA Style

                            
                                
                                    Björn Dahlöf, 
                                
                                    Richard B. Devereux, 
                                
                                    Sverre E. Kjeldsen
                                
                                et al.
                            
                            (2002). 
                            Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. 
                            The Lancet
                            , 359
                            (9311)
                            , 995-1003.
                            https://doi.org/10.1016/s0140-6736(02)08089-3
                        

Identifiers

DOI: 10.1016/s0140-6736(02)08089-3